Not available
Quote | Acasti Pharma Inc. (NASDAQ:ACST)
Last: | $3.425 |
---|---|
Change Percent: | -0.59% |
Open: | $3.42 |
Close: | $3.425 |
High: | $3.425 |
Low: | $3.37 |
Volume: | 33,115 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Acasti Pharma Inc. (NASDAQ:ACST)
2024-02-12 11:14:07 ET More on Acasti Pharma Seeking Alpha’s Quant Rating on Acasti Pharma Historical earnings data for Acasti Pharma Financial information for Acasti Pharma Read the full article on Seeking Alpha For further details see: Ac...
Projected Cash Runway Extends into Second Calendar Quarter 2026, Well Beyond Potential 1H 2025 Submission of GTX-104 New Drug Application (NDA) Patient Enrollment in Pivotal STRIVE-ON Phase 3 Trial Continues, On Track for NDA Submission Timeline Poster Highlighting the STRIVE-ON...
Message Board Posts | Acasti Pharma Inc. (NASDAQ:ACST)
Subject | By | Source | When |
---|---|---|---|
Looks pretty positive | georgie18 | investorshub | 06/21/2023 11:24:18 AM |
$ACST bulls and bears | Eurotradr | investorshub | 06/18/2023 3:34:31 PM |
short squeeze article | Eurotradr | investorshub | 06/18/2023 12:45:36 PM |
$ACST Good news recently, we should start to see this one move | georgie18 | investorshub | 06/14/2023 5:48:39 PM |
$ACST should we be shorting? | xLeGenDx | investorshub | 06/13/2023 3:22:26 AM |
News, Short Squeeze, Breakout and More Instantly...
Projected Cash Runway Extends into Second Calendar Quarter 2026, Well Beyond Potential 1H 2025 Submission of GTX-104 New Drug Application (NDA) Patient Enrollment in Pivotal STRIVE-ON Phase 3 Trial Continues, On Track for NDA Submission Timeline Poster Highlighting the STRIVE-ON...
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (Acasti or the Company), a late-stage, biopharma company adv...
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (...